154 related articles for article (PubMed ID: 32109341)
1. Identification and characterization of alternative STK39 transcripts within human and mouse kidneys reveals species-specific regulation of blood pressure.
Mercado CJ; Wang X; Grimm PR; Welling PA; Chang YC
Physiol Rep; 2020 Feb; 8(4):e14379. PubMed ID: 32109341
[TBL] [Abstract][Full Text] [Related]
2. Regulation of NKCC2 activity by inhibitory SPAK isoforms: KS-SPAK is a more potent inhibitor than SPAK2.
Park HJ; Curry JN; McCormick JA
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1687-96. PubMed ID: 24133122
[TBL] [Abstract][Full Text] [Related]
3. Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules.
Grimm PR; Coleman R; Delpire E; Welling PA
J Am Soc Nephrol; 2017 Sep; 28(9):2597-2606. PubMed ID: 28442491
[TBL] [Abstract][Full Text] [Related]
4. STE20/SPS1-related proline/alanine-rich kinase (SPAK) is critical for sodium reabsorption in isolated, perfused thick ascending limb.
Cheng CJ; Yoon J; Baum M; Huang CL
Am J Physiol Renal Physiol; 2015 Mar; 308(5):F437-43. PubMed ID: 25477470
[TBL] [Abstract][Full Text] [Related]
5. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction.
Yang SS; Lo YF; Wu CC; Lin SW; Yeh CJ; Chu P; Sytwu HK; Uchida S; Sasaki S; Lin SH
J Am Soc Nephrol; 2010 Nov; 21(11):1868-77. PubMed ID: 20813865
[TBL] [Abstract][Full Text] [Related]
6. SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner.
Grimm PR; Taneja TK; Liu J; Coleman R; Chen YY; Delpire E; Wade JB; Welling PA
J Biol Chem; 2012 Nov; 287(45):37673-90. PubMed ID: 22977235
[TBL] [Abstract][Full Text] [Related]
7. Generation of Hypertension-Associated STK39 Polymorphism Knockin Cell Lines With the Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 System.
Mandai S; Mori T; Sohara E; Rai T; Uchida S
Hypertension; 2015 Dec; 66(6):1199-206. PubMed ID: 26416847
[TBL] [Abstract][Full Text] [Related]
8. Critical role of the SPAK protein kinase CCT domain in controlling blood pressure.
Zhang J; Siew K; Macartney T; O'Shaughnessy KM; Alessi DR
Hum Mol Genet; 2015 Aug; 24(16):4545-58. PubMed ID: 25994507
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanisms of Na+ retention in obesity: phosphorylation of NKCC2 and regulation of SPAK/OSR1 by AMPK.
Davies M; Fraser SA; Galic S; Choy SW; Katerelos M; Gleich K; Kemp BE; Mount PF; Power DA
Am J Physiol Renal Physiol; 2014 Jul; 307(1):F96-F106. PubMed ID: 24808538
[TBL] [Abstract][Full Text] [Related]
10. SPAK and WNK kinases: a new target for blood pressure treatment?
Glover M; O'shaughnessy KM
Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):16-22. PubMed ID: 21088576
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways.
Richardson C; Sakamoto K; de los Heros P; Deak M; Campbell DG; Prescott AR; Alessi DR
J Cell Sci; 2011 Mar; 124(Pt 5):789-800. PubMed ID: 21321328
[TBL] [Abstract][Full Text] [Related]
12. Potassium depletion stimulates Na-Cl cotransporter
Ishizawa K; Xu N; Loffing J; Lifton RP; Fujita T; Uchida S; Shibata S
Biochem Biophys Res Commun; 2016 Nov; 480(4):745-751. PubMed ID: 27942049
[TBL] [Abstract][Full Text] [Related]
13. SPAK and OSR1 play essential roles in potassium homeostasis through actions on the distal convoluted tubule.
Ferdaus MZ; Barber KW; López-Cayuqueo KI; Terker AS; Argaiz ER; Gassaway BM; Chambrey R; Gamba G; Rinehart J; McCormick JA
J Physiol; 2016 Sep; 594(17):4945-66. PubMed ID: 27068441
[TBL] [Abstract][Full Text] [Related]
14. Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters.
Mercier-Zuber A; O'Shaughnessy KM
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):534-40. PubMed ID: 21610494
[TBL] [Abstract][Full Text] [Related]
15. Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT.
Glover M; Zuber AM; O'Shaughnessy KM
Cardiovasc Ther; 2011 Feb; 29(1):68-76. PubMed ID: 21167012
[TBL] [Abstract][Full Text] [Related]
16. SPAK differentially mediates vasopressin effects on sodium cotransporters.
Saritas T; Borschewski A; McCormick JA; Paliege A; Dathe C; Uchida S; Terker A; Himmerkus N; Bleich M; Demaretz S; Laghmani K; Delpire E; Ellison DH; Bachmann S; Mutig K
J Am Soc Nephrol; 2013 Feb; 24(3):407-18. PubMed ID: 23393317
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.
Vitari AC; Thastrup J; Rafiqi FH; Deak M; Morrice NA; Karlsson HK; Alessi DR
Biochem J; 2006 Jul; 397(1):223-31. PubMed ID: 16669787
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia.
Glover M; O'Shaughnessy KM
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):876-84. PubMed ID: 23683032
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models.
Liu Z; Xie J; Wu T; Truong T; Auchus RJ; Huang CL
Hum Mol Genet; 2011 Mar; 20(5):855-66. PubMed ID: 21131289
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological targeting of SPAK kinase in disorders of impaired epithelial transport.
Zhang J; Karimy JK; Delpire E; Kahle KT
Expert Opin Ther Targets; 2017 Aug; 21(8):795-804. PubMed ID: 28679296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
